Articles
| Open Access |
DOI:
https://doi.org/10.37547/supsci-ojmp-02-06-03
GENERAL CHARACTERISTICS OF PATIENTS WITH COPD DEPENDING ON THE PRESENCE OF METABOLIC SYNDROME IN THEM
M. B. Kholjigitova , Samarkand State University Samarkand, Uzbekistan N. N. Ubaidullaeva , The center of training and information-methodical work under the Ministry of Medicine of the Republic of Uzbekistan Tashkent, UzbekistanAbstract
Chronic obstructive pulmonary disease (COPD) is a disease that is widespread throughout the world. As a nosological unit, COPD took shape only a few decades ago, and currently causes 2.9 million deaths per year (1). According to the World Health Organization, COPD is considered one of the leading causes of death among noncommunicable diseases (2). Occurring in a group of people older than 40 years, COPD is often combined with the pathology of other organs and systems (4).
According to the definition of COPD, which is included in the main COPD management document - the Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2014, the huge role of comorbidities in increasing the severity of COPD is emphasized , impact on quality of life (QoL), prognosis and survival. Among the numerous comorbidities considered are cardiovascular diseases, metabolic syndrome (MS) and diabetes mellitus (DM) (3,5).
In the available literature, there are practically no clinical studies performed using a systematic approach to assessing the effect of MS components on clinical and instrumental characteristics and quality of life in COPD patients.
Keywords
Chronic, obstructive, pulmonary disease
References
Айрапетова Н.С. Хроническая обструктивная болезнь легких: лечение, реабилитация, профилактика / Н.С. Айрапетова // Физиотерапия, бальнеология и реабилитация. – 2009. – № 2. – С. 49-53.
Антипина А.Н. Особенности клинико-лабораторных проявлений хронической обструктивной болезни легких у больных с ожирением различной степени: дис. …канд. мед. наук / А. Н. Антипина. – Тюмень, 2011. – 116 с.
Белевский А.С. Андрей Белевский: «Проблема ХОБЛ еще не решена, но наши возможности расширились» / А.С. Белевский // Ремедиум. Журнал о российском рынке лекарств и медицинской технике. − 2013. − № 5. − С. 34-35.
Королева А.А. Принципы лечения хронической обструктивной болезни легких с позиций GOLD 2014 года / А. А. Королева, Ю. Л. Журавков, С. М. Метельский // Военная медицина. - 2014. - №2.-С.102-105.
Ожирение и метаболические нарушения у больных хронической обструктивной болезнью легких: возможности фенотипирования / Е.И. Саморукова, Ю.В. Малиничева, В.С. Задионченко // Пульмонология. − 2014. − № 5. − С. 32-38.
Рекомендации по ведению больных с метаболическим синдромом. Клинические рекомендации. – Москва, 2013. – 43 с.
Chandy D. Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease / D. Chandy [et al.] // Integr Blood Press Control. – 2013. – N 6. – P. 101-9.
Improved exercise tolerance can be achieved in chronic obstructive pulmonary disease (COPD) by means of non-pharmacological treatment / P.J. Wijkstra [et al] // Ned. Tijdschr. Geneeskd. – 2009. – Vol. 150,
Article Statistics
Copyright License
Copyright (c) 2022 M. B. Kholjigitova, N. N. Ubaidullaeva
This work is licensed under a Creative Commons Attribution 4.0 International License.